BlackRock Institutional Trust’s Perspective Therapeutics CATX Stock Holding History

BlackRock Institutional Trust’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$533K	Hold	91,827	–	–	﹤0.01%	3443
2016 Q3	$661K	Hold	91,827	–	–	﹤0.01%	3419
2016 Q2	$799K	Hold	91,827	–	–	﹤0.01%	3386
2016 Q1	$826K	Hold	91,827	–	–	﹤0.01%	3333
2015 Q4	$861K	Hold	91,827	–	–	﹤0.01%	3363
2015 Q3	$1.29M	Buy	91,827 +20,288	+28%	+$293K	﹤0.01%	3258
2015 Q2	$1.06M	Buy	71,539 +48,115	+205%	+$780K	﹤0.01%	3342
2015 Q1	$368K	Buy	23,424 +18,878	+415%	+$280K	﹤0.01%	3558
2014 Q4	$66K	Sell	4,546 -1,199	-21%	-$19K	﹤0.01%	3744
2014 Q3	$97K	Sell	5,745 -116	-2%	-$2.87K	﹤0.01%	3675
2014 Q2	$183K	Buy	+5,861	New	+$147K	﹤0.01%	3708

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

CAG

Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

BlackRock Institutional Trust's CATX Position: Q4 2016 in Review

BlackRock Institutional Trust held its Perspective Therapeutics (CATX) position steady in Q4 2016 at 91,827 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

BlackRock Institutional Trust first reported a position in CATX in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.29M in Q3 2015. 30 funds tracked by Wall St. Rank hold CATX as of Q4 2016.

BlackRock Institutional Trust held 91,827 shares of Perspective Therapeutics worth $533K as of Q4 2016.
BlackRock Institutional Trust left its Perspective Therapeutics share count unchanged in Q4 2016.
Perspective Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3443 holding.
BlackRock Institutional Trust first reported a position in Perspective Therapeutics in Q2 2014 and has held it in 11 quarters since.
BlackRock Institutional Trust's Perspective Therapeutics position peaked at $1.29M in Q3 2015.
30 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.